Back to SNY Stock Lookup

SNY Related Press Releases

Jun 17, 2013 08:00 AM Leading Experts in Parenting, Education and Medicine Partner to Launch Head Lice Awareness Initiative

Jun 12, 2013 08:00 AM Genzyme Convenes 14th Annual North American Lysosomal Storage Disorder Registries Meeting

Jun 10, 2013 11:17 AM Former EnerNOC and Siemens Executives Join Bluestone Energy Services

Jun 10, 2013 07:00 AM New Four-Strain Influenza Vaccine from Sanofi Pasteur Now Licensed By FDA for Broad Age Range of Children and Adults

Jun 10, 2013 07:00 AM Xenon Licenses Antisense Drug XEN701 From Isis and Initiates Preclinical Toxicology Studies

Jun 7, 2013 09:00 AM BioPharm America™ 2013 Program Leads with Plenary on Drug Development Pipeline “The Chameleon Rubik’s Cube”

Jun 6, 2013 04:00 PM Alnylam to Webcast Presentation at Goldman Sachs 34th Annual Global Healthcare Conference

Jun 6, 2013 10:46 AM UPDATE: Jean-Jacques Bienaime, CEO of BioMarin, to Present at the Goldman Sachs Global Healthcare Conference

Jun 6, 2013 09:00 AM BioMarin to Present at the Goldman Sachs Global Healthcare Conference

Jun 6, 2013 08:30 AM PARTNERS+simons Grows Team with Three Strategic Hires

Jun 6, 2013 07:00 AM Isis Pharmaceuticals Earns $6 Million Payment from AstraZeneca

Jun 5, 2013 08:00 AM Emmy® Award-Winning Actress Sarah Michelle Gellar Joins March of Dimes and Sanofi Pasteur on the Sounds of Pertussis® Campaign

Jun 5, 2013 07:00 AM Isis Pharmaceuticals to Present at the Goldman Sachs 34th Annual Global Healthcare Conference

Jun 5, 2013 06:00 AM BioMarin Initiates Phase 3 Trial for PEG-PAL for the Treatment of PKU

Jun 4, 2013 10:30 AM Sanofi US Announces Winner of 2013 Data Design Diabetes Innovation Challenge -- Prove It!

Jun 3, 2013 02:00 PM Isis Pharmaceuticals Reports Encouraging Data on ISIS-STAT3rx in Patients With Cancer

Jun 3, 2013 09:00 AM BioMarin Provides Preliminary Data on Ongoing Phase 1/2 Trial for BMN 673 for the Treatment of Solid Tumors at 2013 American Society of Clinical Oncology Annual Meeting

Jun 3, 2013 08:00 AM 89 Degrees and IKEA Share Success Story at CRMC

Jun 3, 2013 07:03 AM Xtalks Announces Its June 2013 Life Sciences Webinar Calendar

Jun 3, 2013 07:00 AM Isis Pharmaceuticals Earns $10 Million Milestone Payment from AstraZeneca for ISIS-AR Rx to Treat Prostate Cancer

May 31, 2013 04:30 PM Isis Pharmaceuticals Announces Exercise of Underwriters' Option to Purchase Additional Shares

May 30, 2013 04:00 PM BioMarin to Present at the Jefferies Global Healthcare Conference

May 30, 2013 08:10 AM MolecularMD Corp. Obtains Exclusive License to Uses of FGFR2 Activating Mutations in Endometrial Cancer

May 30, 2013 07:05 AM FDA Accepts Vimizim BLA and Grants Priority Review Designation

May 30, 2013 07:00 AM Vimizim MAA Validated by the EMA

May 29, 2013 09:00 AM Genzyme Celebrates Fifth Annual World MS Day

May 23, 2013 07:00 AM Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference

May 21, 2013 04:00 PM Alnylam to Webcast Presentation at Deutsche Bank 38th Annual dbAccess Health Care Conference

May 21, 2013 08:15 AM Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine

May 21, 2013 02:00 AM Sanofi Relies on Axway to Future-Proof their Infrastructure and Reduce Operational Costs through Global Consolidation

May 20, 2013 09:00 AM BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

May 17, 2013 08:00 AM Alnylam Presents Key Pre-Clinical Proof-of-Concept Data for ALN-AS1, an RNAi Therapeutic Targeting Aminolevulinate Synthase-1 (ALAS-1) for the Treatment of Porphyria

May 17, 2013 08:00 AM Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis

May 16, 2013 05:49 PM BioMarin Announces BMN-673 Data in Breast and Ovarian Cancers to be Released at ASCO

May 16, 2013 08:00 AM Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma and Allergy Awareness Month

May 15, 2013 04:00 PM Alnylam to Webcast Presentation at 2013 UBS Global Healthcare Conference

May 15, 2013 01:00 AM Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)

May 14, 2013 09:00 AM BioMarin to Present at the UBS Global Healthcare Conference

May 14, 2013 07:00 AM Jack Green Joins Verastem as Chief Financial Officer

May 13, 2013 10:00 AM PatientsLikeMe and CISCRP Team up with Sanofi to Spotlight Medical Heroes and Clinical Trial Participation

May 13, 2013 07:00 AM Isis Pharmaceuticals to Present at the 2013 UBS Global Healthcare Conference

May 9, 2013 04:34 PM Isis Pharmaceuticals Earns $3.5 Million from Biogen Idec

May 9, 2013 04:06 PM NeoStem CEO's Letter to Shareholders

May 9, 2013 02:39 PM Isis Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

May 9, 2013 10:41 AM T2 Biosystems Named 2013 SBANE New England Innovation Award Winner

May 9, 2013 07:46 AM BG Medicine Appoints Dr. Paul Sohmer as Chief Executive Officer

May 8, 2013 09:50 PM Isis Pharmaceuticals Prices Public Offering Of Common Stock

May 8, 2013 04:00 PM Alnylam to Webcast Presentation at 2013 Bank of America Merrill Lynch Health Care Conference

May 7, 2013 04:08 PM Isis Pharmaceuticals Announces Proposed Public Offering of Common Stock

May 7, 2013 04:05 PM Isis Reports Financial Results and Highlights for First Quarter 2013

Back to SNY Stock Lookup